Erasmus MC
Erasmus MC
Rotterdam, South Holland, Netherlands3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT05927142 | |
| Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, brain disorder, brain ischemia, cardiovascular disorder, carotid artery disorder, carotid stenosis, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, transient ischemic attack, vascular disorder | Recruiting | Not applicable | 2026-05-15 | NCT07556887 | |
| Long-term Pain Modulation by Intravenous Esketamine in CRPS | autonomic nervous system disorder, complex regional pain syndrome, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Enrolling by invitation | Not applicable | 2023-09-11 | NCT05212571 |